FEZF2
Basic information
Region (hg38): 3:62369681-62374324
Previous symbols: [ "ZNF312" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEZF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 2 | 2 |
Variants in FEZF2
This is a list of pathogenic ClinVar variants found in the FEZF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-62370112-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
3-62370139-T-C | not specified | Uncertain significance (Jan 11, 2023) | ||
3-62370157-CAT-C | Uncertain significance (Dec 15, 2023) | |||
3-62370197-G-C | Neurodevelopmental disorder | Likely pathogenic (Oct 09, 2024) | ||
3-62370205-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
3-62370206-G-T | Uncertain significance (Dec 07, 2022) | |||
3-62370292-A-C | Uncertain significance (Jun 07, 2023) | |||
3-62371226-GA-G | Uncertain significance (Jun 24, 2022) | |||
3-62371247-C-T | FEZF2-related disorder | Uncertain significance (Dec 01, 2023) | ||
3-62371260-C-G | FEZF2-related disorder | Uncertain significance (Jun 01, 2024) | ||
3-62371307-G-A | Uncertain significance (Oct 25, 2023) | |||
3-62371316-C-CT | Uncertain significance (Dec 09, 2022) | |||
3-62371330-T-C | not specified | Uncertain significance (Dec 16, 2023) | ||
3-62371576-C-A | FEZF2-related disorder | Uncertain significance (Feb 07, 2024) | ||
3-62371669-T-A | Uncertain significance (May 19, 2022) | |||
3-62372058-C-G | not specified | Uncertain significance (Aug 08, 2023) | ||
3-62372066-C-CCT | Neurodevelopmental phenotype | Likely pathogenic (Oct 28, 2024) | ||
3-62372118-C-A | not specified | Uncertain significance (Feb 13, 2024) | ||
3-62372119-CGA-C | Uncertain significance (Jan 04, 2024) | |||
3-62372201-G-A | not specified | Uncertain significance (May 25, 2022) | ||
3-62372271-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
3-62372370-C-T | not specified | Uncertain significance (Jul 16, 2024) | ||
3-62372376-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
3-62372505-C-T | Uncertain significance (Nov 08, 2023) | |||
3-62372510-A-C | not specified | Uncertain significance (Sep 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEZF2 | protein_coding | protein_coding | ENST00000283268 | 4 | 4644 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0114 | 112048 | 0 | 1 | 112049 | 0.00000446 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.07 | 156 | 248 | 0.629 | 0.0000113 | 2930 |
Missense in Polyphen | 16 | 51.777 | 0.30902 | 537 | ||
Synonymous | -1.51 | 131 | 111 | 1.18 | 0.00000543 | 942 |
Loss of Function | 3.40 | 0 | 13.5 | 0.00 | 5.73e-7 | 175 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000329 | 0.0000329 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription repressor. Required for the specification of corticospinal motor neurons and other subcerebral projection neurons. May play a role in layer and neuronal subtype-specific patterning of subcortical projections and axonal fasciculation. Controls the development of dendritic arborization and spines of large layer V pyramidal neurons. May be involved in innate immunity (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.68
Haploinsufficiency Scores
- pHI
- 0.532
- hipred
- Y
- hipred_score
- 0.789
- ghis
- 0.643
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.630
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fezf2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; taste/olfaction phenotype; craniofacial phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- fezf2
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- dead
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;axon guidance;axonal fasciculation;locomotory behavior;negative regulation of cell population proliferation;dendrite development;dentate gyrus development;forebrain anterior/posterior pattern specification;cerebral cortex GABAergic interneuron migration;commitment of neuronal cell to specific neuron type in forebrain;cell dedifferentiation;negative regulation of neuron differentiation;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;neuron fate determination;regulation of axon guidance
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;chromatin DNA binding;sequence-specific DNA binding;metal ion binding